Insmed INSM
NASDAQ INSM
$125.77 +0.69 (+0.55%)
At close: Aug 21, 2026 · 4:00 PM EDT

Insmed (INSM) Interest & Investment Income (2010 - 2026)

Insmed (INSM) posted quarterly Interest & Investment Income of $12.0 million for Q1 2026, down 13.42% year-over-year from $13.9 million in Q1 2025, and down 20.98% quarter-over-quarter from $15.2 million in Q4 2025.

Insmed (INSM) Interest & Investment Income (2010 - 2026) Analysis & Trends

Insmed's Interest & Investment Income history runs 17 years deep, the most recent figure standing at $12.0 million for Q1 2026.

  • In Q1 2026, Interest & Investment Income fell 13.42% year-over-year to $12.0 million; the TTM figure through Mar 2026 stood at $58.8 million (up 0.62% YoY), while the FY2025 annual figure was $60.7 million, up 13.79% from the prior year.
  • Interest & Investment Income for Q1 2026 stood at $12.0 million, down from $15.2 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $18.3 million in Q3 2025, with the low at $137000.0 in Q1 2022.
  • The 5-year median for Interest & Investment Income is $10.6 million (2023), against an average of $10.5 million.
  • The sharpest annual moves came in 2022 and 2024: Interest & Investment Income surged 13536.07% in 2022, then fell 16.54% in 2024.
  • Insmed's Interest & Investment Income stood at $8.3 million in 2022, then rose by 18.45% to $9.9 million in 2023, then jumped by 75.14% to $17.3 million in 2024, then retreated by 11.71% to $15.2 million in 2025, then decreased by 20.98% to $12.0 million in 2026.
  • Business Quant data shows INSM's Interest & Investment Income at $12.0 million in Q1 2026, $15.2 million in Q4 2025, and $18.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 67.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 27.90 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 28.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 115.94 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 10.98 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 5.13 Mn
10 Roivant Sciences 26.20 Bn 26.20 Bn 1.16 Mn 36.92 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 10.98 Mn
Mar 31, 2026 12.04 Mn
Dec 31, 2025 15.24 Mn
Sep 30, 2025 18.29 Mn
Jun 30, 2025 13.23 Mn
Mar 31, 2025 13.91 Mn
Dec 31, 2024 17.26 Mn
Sep 30, 2024 16.98 Mn
Jun 30, 2024 10.29 Mn
Mar 31, 2024 8.78 Mn
Dec 31, 2023 9.85 Mn
Sep 30, 2023 10.58 Mn
Jun 30, 2023 11.17 Mn
Mar 31, 2023 10.52 Mn
Dec 31, 2022 8.32 Mn
Sep 30, 2022 1.79 Mn
Jun 30, 2022 835,000.00
Mar 31, 2022 137,000.00
Dec 31, 2021 61,000.00
Sep 30, 2021 46,000.00